These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6399071)

  • 1. Activity of cycloserine and structurally related compounds against M. leprae-infected mice.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):536-8. PubMed ID: 6399071
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimal bactericidal dietary concentration of minocycline for Mycobacterium leprae-infected mice is very low and similar to its minimal inhibitory dietary concentration.
    Gelbert RH; Siu P; Tsang M; Murray LP
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):276-7. PubMed ID: 1522371
    [No Abstract]   [Full Text] [Related]  

  • 3. The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide.
    Gelber RH
    Lepr Rev; 1987 Dec; 58(4):407-11. PubMed ID: 3323753
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
    Franzblau SG; Parrilla ML; Chan GP
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):66-9. PubMed ID: 8392100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice.
    Saito H; Tomioka H; Nagashima K
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    Shepard CC; Van Landingham RM; Walker LL; Good RC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice.
    Gelber RH; Murray LP; Siu P; Tsang M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):485-7. PubMed ID: 1474290
    [No Abstract]   [Full Text] [Related]  

  • 10. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line.
    Azouaou N; Gelber RH; Abel K; Sasaki DT; Murray LP; Locksley RM; Mohagheghpour N
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):398-405. PubMed ID: 8228438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648.
    Tomioka H; Saito H
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):255-8. PubMed ID: 8371034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.